Companies / Corcept Therapeutics Inc
Corcept Therapeutics Inc
Financials · FY2025
Ownership
108.1M shares outstanding · as of Jul 22, 2026
Ownership
| Insiders | 10.06% | 10,875,642 |
| 10%+ / strategic | 12.05% | 13,021,994 |
| Institutions | 64.39% | 69,604,174 |
| Public float | 13.50% | 14,596,587 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
Baker G Leonard JrDirector | 5.13% | 5,550,196 |
Belanoff Joseph KCEOChief Executive Officer · Director | 2.65% | 2,865,489 |
Mahoney David LDirector | 1.17% | 1,263,292 |
Wilson James NDirector | 1.01% | 1,094,543 |
Hunt HazelFormerChief Scientific Officer | 0.24% | 255,437 |
Maduck SeanSee Remarks | 0.04% | 43,755 |
Robb Gary CharlesChief Business Officer | 0.04% | 38,252 |
Mokari AtabakChief Financial Officer | 0.01% | 16,130 |
Lyon Joseph DouglasFormerSee Remarks | <0.01% | 7,035 |
Guyer WilliamChief Development Officer | <0.01% | 3,985 |
Institutional holders 405
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.08B | 11.50% | |
| $330.42M | 8.78% | |
| $285.15M | 3.03% | |
| $229.07M | 5.26% | |
| $134.99M | 3.59% | |
| $109.40M | 2.51% | |
| $87.61M | 2.01% | |
| $84.03M | 2.23% | |
| $60.47M | 1.39% | |
| $56.58M | 1.50% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | Maduck Sean Executive | Sell | Common Stock | $3.57M | -55K -64.99% | 29,402 0.03% of shares | medium |
| Feb 9, 2026 | Hunt Hazel Executive | Other | Common Stock | $3.22M | -78K -23.39% | 255,437 0.24% of shares | low |
| Jun 1, 2026 | Mokari Atabak Executive | Sell | Common Stock | $2.80M | -40K -72.39% | 15,257 0.01% of shares | medium |
| Mar 17, 2026 | Baker G Leonard Jr Director | Buy | Common Stock | $2.50M | +76K +7.24% | 1,122,413 1.04% of shares | high |
| May 1, 2026 | Belanoff Joseph K CEO | Sell | Common Stock | $2.00M | -40K -1.37% | 2,878,326 2.66% of shares | medium |
| Jun 17, 2026 | Mahoney David L Director | Sell | Common Stock | $1.69M | -20K -43.34% | 26,147 0.02% of shares | medium |
| Jun 15, 2026 | Mokari Atabak Executive | Sell | Common Stock | $1.59M | -19K -54.70% | 16,132 0.01% of shares | medium |
| Jun 1, 2026 | Maduck Sean Executive | Sell | Common Stock | $1.48M | -21K -62.01% | 12,908 0.01% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Renaissance Technologies LLC | Passive13G/A | — |
| INGALLS & SNYDER LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CORT | — | 218352102 |